Khiron Life Sciences Leads in LatAm Cannabis Market

Investors are always on the hunt for the next big thing. And in cannabis, we may have already found ours…

Latin America.

The countries here are home to more than 620 million consumers.

And Latin America is shaping up to be one of the fastest-growing cannabis markets in the world. Projections have it exploding from $125 million in 2018 to nearly $13 billion by 2028.

This provides tremendous opportunities for first movers. And the leader here is Khiron Life Sciences Corp. (OTC: KHRNF).

Based out of Colombia, Khiron has one of the largest grow operations in Latin America. It has a 1.9 million-square-foot facility in Colombia, as well as another 5.6 million square feet in three other countries.

Combined, the company’s potential annual production could be 158,000 kilograms.

Even better, its cost to produce is extremely low – a mere CA$0.35 per gram.

At the moment, Khiron has partnerships and operations spanning nine countries. And it’s involved in a variety of marijuana product markets, from beauty and CBD to medical and recreational.

But it’s the Latin American powerhouse’s recent series of headline-making deals that I wanted to know more about. And that’s why I invited Khiron President Chris Naprawa to join me on CannaBiz Now!

Naprawa shared with me how big he believes Khiron’s piece of the pie could be. We talked about the groundbreaking deals the company has inked in the past few weeks. And we discussed Khiron’s plans for international expansion.

Latin American cannabis is about to heat up. And Khiron Life Sciences is taking the lead in this frontier market.